Associated Banc-Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.38M | Sell |
7,583
-580
| -7% | -$258K | 0.1% | 137 |
|
2025
Q1 | $3.96M | Sell |
8,163
-665
| -8% | -$322K | 0.12% | 129 |
|
2024
Q4 | $3.56M | Sell |
8,828
-291
| -3% | -$117K | 0.11% | 133 |
|
2024
Q3 | $4.24M | Sell |
9,119
-362
| -4% | -$168K | 0.12% | 128 |
|
2024
Q2 | $4.44M | Sell |
9,481
-143
| -1% | -$67K | 0.14% | 122 |
|
2024
Q1 | $4.02M | Sell |
9,624
-131
| -1% | -$54.8K | 0.13% | 128 |
|
2023
Q4 | $3.97M | Sell |
9,755
-99
| -1% | -$40.3K | 0.14% | 127 |
|
2023
Q3 | $3.43M | Sell |
9,854
-48
| -0.5% | -$16.7K | 0.13% | 129 |
|
2023
Q2 | $3.48M | Buy |
9,902
+5
| +0.1% | +$1.76K | 0.13% | 130 |
|
2023
Q1 | $3.12M | Sell |
9,897
-807
| -8% | -$254K | 0.13% | 134 |
|
2022
Q4 | $3.09M | Sell |
10,704
-202
| -2% | -$58.3K | 0.13% | 131 |
|
2022
Q3 | $3.16M | Sell |
10,906
-121
| -1% | -$35K | 0.15% | 128 |
|
2022
Q2 | $3.11M | Sell |
11,027
-448
| -4% | -$126K | 0.14% | 128 |
|
2022
Q1 | $3M | Sell |
11,475
-9,122
| -44% | -$2.38M | 0.12% | 138 |
|
2021
Q4 | $4.52M | Sell |
20,597
-5,480
| -21% | -$1.2M | 0.17% | 117 |
|
2021
Q3 | $4.73M | Sell |
26,077
-3,982
| -13% | -$722K | 0.19% | 112 |
|
2021
Q2 | $6.06M | Buy |
30,059
+22,225
| +284% | +$4.48M | 0.24% | 101 |
|
2021
Q1 | $1.86M | Sell |
7,834
-65,697
| -89% | -$15.6M | 0.12% | 132 |
|
2020
Q4 | $17.4M | Buy |
73,531
+32,417
| +79% | +$7.66M | 0.68% | 43 |
|
2020
Q3 | $11.2M | Buy |
41,114
+23,680
| +136% | +$6.44M | 0.48% | 55 |
|
2020
Q2 | $5.06M | Buy |
17,434
+9,595
| +122% | +$2.79M | 0.23% | 103 |
|
2020
Q1 | $1.87M | Buy |
+7,839
| New | +$1.87M | 0.1% | 155 |
|